BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yan F, Xue XL, Guo Y, Zhang QR, You RR, Shang J, Wu XP, Geng JW, Gao XH, Ye Q, Liang J, Wang XY, Zeng JY, Chen J, Lin YC, Chen XY, Du Q, Yin WL, Liu L, Wang F, Xu BG, Zhang WH, Xiang HL. Baseline hepatitis B surface antigen and cirrhosis predict extended interferon therapy in chronic hepatitis B: A retrospective study. World J Gastroenterol 2026; 32(12): 116287 [DOI: 10.3748/wjg.v32.i12.116287]
URL: https://www.wjgnet.com/1007-9327/full/v32/i12/116287.htm
Number Citing Articles
1
Cheng-Yuan Tsai, Ching-Shan Huang. Predictive model to identify patients requiring extended interferon therapy in chronic hepatitis BWorld Journal of Gastroenterology 2026; 32(37): 119736 doi: 10.3748/wjg.119736
2
Ling-Feng Zou, Shao-Ding Yu, Yan Luo, Cheng-Long Wang. Biological interpretation of baseline hepatitis B surface antigen and cirrhosis in determining interferon treatment durationWorld Journal of Gastroenterology 2026; 32(38): 119697 doi: 10.3748/wjg.119697